Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Innate Pharma
Innate Pharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
Innate Pharma and Sanofi launch NK cell engager programme
Under the terms of a new license agreement, Innate will receive €25m upfront payment and up to €1.35bn total in preclinical, clinical, regulatory
Regulatory
FDA lifts partial clinical hold for GMP deficiencies
The US FDA has lifted partial clinical hold on Innate Pharma's Lacutamab Tellomak trial in advanced T cell lymphomas
Research & Development
Bristol-Myers Squibb and Innate Pharma sign licensing agreement
BM-S pays US$35m for global rights to an immuno-oncology biologic
Research & Development
French biotechs establish Platine Pharma Services
To provide immunomonitoring services to the healthcare industry
Subscribe now